Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin

OBJECTIVE: Use of gastric bypass surgery is common and increasing. Over 40% of patients in diabetes remission after gastric bypass surgery may redevelop diabetes within 5 years. Metformin, the first-line drug for diabetes, has low bioavailability and slow, incomplete gastrointestinal absorption. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Padwal, Raj S., Gabr, Raniah Q., Sharma, Arya M., Langkaas, Lee-Ann, Birch, Dan W., Karmali, Shahzeer, Brocks, Dion R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114332/
https://www.ncbi.nlm.nih.gov/pubmed/21478461
http://dx.doi.org/10.2337/dc10-2140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114332/
https://www.ncbi.nlm.nih.gov/pubmed/21478461
http://dx.doi.org/10.2337/dc10-2140

Ejemplares similares